MCL Elderly III

Kategorie: Indolente Lymphome/MCL

Leiter: Herr Univ. Prof. Dr. med. Georg Heß

 

Venetoclax in combination with the BTK inhibitor Ibrutinib and rituximab or conventional chemotherapy (bendamustine) and ibrutinib and rituximab in patients with treatment naïve Mantle Cell Lymphoma not eligible for high dose therapy - The European Mantle Cell Lymphoma Elderly III-Trial

 
Zusätzliche Dokumente
 

Herr Univ. Prof. Dr. med. Georg Heß

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

E-Mail senden